Section 1 Short title
This Act may be cited as the “BioTech Innovation and National Security Continuation Act”.
BioTech Innovation and National Security Continuation Act
A BILL
To modify the National Security Commission on Emergency Biotechnology.
Sec. 2 Modification of National Security Commission on Emerging Biotechnology
Section 1091 of the National Defense Authorization Act for Fiscal Year 2022 (Public Law 117–81) is amended—
in subsection (b)(3) by striking “the authority to make such appointment or appointments shall expire, and the number of members of the Commission shall be reduced by the number equal to the number of appointments so not made” and inserting “such appointments shall nevertheless be considered valid”;
in subsection (g)(1), by inserting “and 6 months” after “3 years”; and
in subsection (r), by striking “18 months after the date on which it submits the final report required by subsection (g)” and inserting “on December 31, 2026”.